Directory
>
Greg Vosganian
Greg Vosganian
Resident Physician | Protagonist Therapeutics
California, Mountain View, United States
Greg Vosganian
Summary
Greg Vosganian is a seasoned Vice President in Clinical Development with extensive experience in hematology and oncology within the biotechnology and pharmaceutical sectors. He has a proven track record in leading clinical trial development and strategy, particularly in innovative cancer treatments and therapies. With a strong background in regulatory submissions and cross-functional team leadership, Greg has successfully navigated complex clinical landscapes to bring new therapies to market. His expertise encompasses biomarkers, clinical research, and stakeholder management, making him a valuable asset in drug development initiatives. Fluent in both French and Armenian, he brings a global perspective to his work, enhancing collaboration in diverse teams. Greg is passionate about advancing cancer treatment options and is actively involved in talent development within the industry.
Greg Vosganian
Work Experience
Vice President Clinical Development at
Protagonist Therapeutics
April 2025 - Present
Greg Vosganian
Education
Stanford University, BS, Biological Sciences
January 1994 - January 1998
Medical College of Virginia, Doctor of Medicine (MD)
January 2001 - January 2005
Bullard
Bullard
Frequently Asked Questions about Greg Vosganian
What is Greg Vosganian email address?
Greg Vosganian's primary email address is ****@protagonist-inc.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Greg Vosganian work for?
Greg Vosganian is a Resident Physician at Protagonist Therapeutics.
Where Greg Vosganian graduated from?
Greg Vosganian holds a degree in null from Stanford University.
How can I directly contact Greg Vosganian?
To contact Greg Vosganian directly, you can use the email address ****@protagonist-inc.com. Complete contact information is available upon registration with Muraena.
Who is Greg Vosganian?
Greg Vosganian is a seasoned Vice President in Clinical Development with extensive experience in hematology and oncology within the biotechnology and pharmaceutical sectors. He has a proven track record in leading clinical trial development and strategy, particularly in innovative cancer treatments and therapies. With a strong background in regulatory submissions and cross-functional team leadership, Greg has successfully navigated complex clinical landscapes to bring new therapies to market. His expertise encompasses biomarkers, clinical research, and stakeholder management, making him a valuable asset in drug development initiatives. Fluent in both French and Armenian, he brings a global perspective to his work, enhancing collaboration in diverse teams. Greg is passionate about advancing cancer treatment options and is actively involved in talent development within the industry.
Greg`s contact details
****@protagonist-inc.com
Colleagues
Senior Director, Finance and Administration
Clinical Research Associate
Portfolio Accountant
Senior Research Scientist
Validation Engineer
Statistician III
Attorney
Jr. Analytical Chemist
Faculty Staff Physician and Adjunct Professor
Associate Production Mgr